Skip Navigation

European Heart Journal 2004 25(22):1970-1971; doi:10.1016/j.ehj.2004.09.005
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Pijls, N. H.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pijls, N. H.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

The interventionalist's dilemma: innocent intimal hyperplasia or in-stent restenosis?

Nico H.J. Pijls*

Department of Cardiology, Catharina Hospital, PO Box 1350, 5602 ZA Eindhoven, The Netherlands

* Correspondence to: Prof. Nico H.J. Pijls, Department of Cardiology, Catharina Hospital, Michelangelolaan, PO Box 1350, 5602 ZA Eindhoven, The Netherlands. Tel.: +31 40 239 7004; fax: +31 40 244 7885 (E-mail: cathreine@wxs.nl).

The first 10% of the full text of this article appears below.

This editorial refers to "Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses" by A. De Bruyne et al. on page 2034 and "Uutility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis" by Lopez-Palop et al. on page 2040.{dagger}

One of the remaining challenges in interventional cardiology is in-stent restenosis. In-stent restenosis is difficult to treat, often recurs, and may require repeated interventions including bypass surgery and is therefore often frustrating for both the patient and the physician.

If in-stent restenosis is severe and the relation with the patient's complaints or proven ischaemia is clear, there will be little discussion about the necessity to use the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses
Emanuele Barbato, Jozef Bartunek, Wilbert Aarnoudse, Marc Vanderheyden, Frank Staelens, William Wijns, Guy R. Heyndrickx, Nico H.J. Pijls, and Bernard De Bruyne
EHJ 2004 25: 2034-2039. [Abstract] [Full Text]  

Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis
Ramon Lopez-Palop, Eduardo Pinar, Íñigo Lozano, Daniel Saura, Francisco Picó, and Mariano Valdés
EHJ 2004 25: 2040-2047. [Abstract] [Full Text]